Brief: XVIVO Q4 Net Income At SEK 31.6 Million
Jan 27 (Reuters) - Xvivo Perfusion AB XVIVO.ST: Q4 EPS SEK 1.01 Q4 EBIT SEK 36.8 MILLION Q4 SALES SEK 226.1 MILLION Q4 NET INCOME SEK 31.6 MILLION BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND BE PAID FOR THE 2025 FINANCIAL YEAR AND THAT RETAINED EARNINGS BE CARRIED FORWARD Source text: ID:nMFN2LNDsf Further company coverage: XVIVO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength